Cardinal Health, Inc. Income (Loss) from Equity Method Investments
Cardinal Health, Inc. (CAH) reported Income (Loss) from Equity Method Investments of $2.00 million for the 12-month period ending 2020-06-30, per its 10-K filed 2021-08-16.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-08-16
- Cardinal Health, Inc. income (loss) from equity method investments for fiscal 2020 was $2.00M, a 80.00% decline from fiscal 2019.
- Cardinal Health, Inc. income (loss) from equity method investments for fiscal 2019 was $10.00M.
| Period end | Income (Loss) from Equity Method Investments 12 month |
|---|---|
| 2020-06-30 | $2.00M 10-K · filed 2021-08-16 |
| 2019-06-30 | $10.00M 10-K · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |